Biopharmaceutical giant Nestlé announced that it will be acquiring Aimmune Therapeutics to create a global leader in food allergy prevention and treatment. According to the company’s press release, Aimmune’s recently approved therapy Palforzia® would expand Nestlé Health Science portfolio with first and only FDA-approved treatment to help reduce the frequency and severity of allergic reactions … Continue reading “Nestlé Health Science to Acquire Aimmune Therapeutics to Create Global Leader in Food Allergy Prevention”
Tag: Aimmune Therapeutics
Biotech & Pharma
Aimmune Shares Explode on Peanut Allergy Treatment Approval from FDA
Aimmune Therapeutics saw its shares flying on Monday after the company gained Food and Drug…
February 3, 2020